
    
      Primary objective:

      1. Improvement on gut health and infant comfort

      Secondary objectiveï¼š

        1. Efficacy on easy digestion;

        2. Changes on SCFA in feces(Baseline and Endpoint)

        3. Improvement on gut microbiome strains(Baseline and Day 21);
           (bifidobacterium/lactobacillus/clostridium perfringens recommended)

        4. Changes on sIgA in feces(Baseline and Endpoint)

        5. Improvement on tolerance(comfort) via infant fussy/bloating/abdominal pain/milk
           regurgitation/sleeping time;

        6. Incidence of eczema and duration;

        7. Infants growth
    
  